Delivery Order SPE2DB25D3201-SPE2DB25FNVWT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,373.84 to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count units) with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on August 18, 2025, with a ceiling value of $1,753.78 and firm fixed pricing. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,897.50 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count units) under a firm fixed price contract. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a contract value of $1,130.40. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a $1,387.02 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 2 mg, a pharmaceutical product used in treating psychiatric conditions. This firm fixed-price delivery order, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Risperdal 2 mg tablets (60-count) with a contract value of $19,929.37. The award is competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order. This order is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Risperidone 3 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,237.70. This non-set-aside award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,409.58 firm fixed price delivery order is for the supply of Risperidone 3 mg tablets. The contract has an ultimate completion date of July 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 18, 2025, procures 60 tablets of Risperdal 2 mg with a ceiling value of $4,281.44. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency's Medical Supply Chain and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This award was competitively awarded with no set-aside designation and represents a...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVWTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 3 mg tablets (60-count) under a firm fixed-price contract valued at $2,186.98. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order represents a child contract action under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/25/25 |